|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1989-5-23
|
|
pubmed:abstractText |
We treated 20 consecutive patients suffering from staphylococcal keratitis with topical fusidic acid 1% suspension in a carbomer gel. Fifteen (79%) of the isolated Staphylococcus epidermidis strains were resistant to methicillin, but all were sensitive to fusidic acid by in-vitro testing. The keratitis showed evidence of healing in 17 (85%) of the 20 patients. The healing times ranged between 5 and 21 days (mean 10.5 days). In this open clinical trial fusidic acid proved to be a safe and effective antibiotic for the treatment of staphylococcal keratitis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0007-1161
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
73
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
136-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2649148-Adolescent,
pubmed-meshheading:2649148-Adult,
pubmed-meshheading:2649148-Aged,
pubmed-meshheading:2649148-Aged, 80 and over,
pubmed-meshheading:2649148-Clinical Trials as Topic,
pubmed-meshheading:2649148-Female,
pubmed-meshheading:2649148-Fusidic Acid,
pubmed-meshheading:2649148-Humans,
pubmed-meshheading:2649148-Keratitis,
pubmed-meshheading:2649148-Male,
pubmed-meshheading:2649148-Microbial Sensitivity Tests,
pubmed-meshheading:2649148-Middle Aged,
pubmed-meshheading:2649148-Prospective Studies,
pubmed-meshheading:2649148-Staphylococcal Infections,
pubmed-meshheading:2649148-Staphylococcus epidermidis,
pubmed-meshheading:2649148-Visual Acuity
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Effects of fusidic acid on staphylococcal keratitis.
|
|
pubmed:affiliation |
King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
